258 related articles for article (PubMed ID: 22430211)
1. Endometrial carcinoma: molecular alterations involved in tumor development and progression.
Yeramian A; Moreno-Bueno G; Dolcet X; Catasus L; Abal M; Colas E; Reventos J; Palacios J; Prat J; Matias-Guiu X
Oncogene; 2013 Jan; 32(4):403-13. PubMed ID: 22430211
[TBL] [Abstract][Full Text] [Related]
2. Endometrial carcinoma: pathology and genetics.
Prat J; Gallardo A; Cuatrecasas M; Catasús L
Pathology; 2007 Feb; 39(1):72-87. PubMed ID: 17365824
[TBL] [Abstract][Full Text] [Related]
3. Molecular carcinogenesis of endometrial cancer.
Liu FS
Taiwan J Obstet Gynecol; 2007 Mar; 46(1):26-32. PubMed ID: 17389185
[TBL] [Abstract][Full Text] [Related]
4. Molecular pathology of endometrial carcinoma.
Matias-Guiu X; Prat J
Histopathology; 2013 Jan; 62(1):111-23. PubMed ID: 23240673
[TBL] [Abstract][Full Text] [Related]
5. [Dualistic model of molecular pathogenesis in endometrial carcinoma].
Lax SF
Zentralbl Gynakol; 2002 Jan; 124(1):10-6. PubMed ID: 11873308
[TBL] [Abstract][Full Text] [Related]
6. Current concepts in the pathology and epigenetics of endometrial carcinoma.
Arafa M; Somja J; Dehan P; Kridelka F; Goffin F; Boniver J; Delvenne P
Pathology; 2010 Dec; 42(7):613-7. PubMed ID: 21080868
[TBL] [Abstract][Full Text] [Related]
7. Molecular and pathologic aspects of endometrial carcinogenesis.
Hecht JL; Mutter GL
J Clin Oncol; 2006 Oct; 24(29):4783-91. PubMed ID: 17028294
[TBL] [Abstract][Full Text] [Related]
8. A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses.
Lax SF; Kurman RJ
Verh Dtsch Ges Pathol; 1997; 81():228-32. PubMed ID: 9474874
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetic changes in epithelial, stromal and mixed neoplasms of the endometrium.
Lax SF
Pathology; 2007 Feb; 39(1):46-54. PubMed ID: 17365822
[TBL] [Abstract][Full Text] [Related]
10. Novel molecular profiles of endometrial cancer-new light through old windows.
Doll A; Abal M; Rigau M; Monge M; Gonzalez M; Demajo S; Colás E; Llauradó M; Alazzouzi H; Planagumá J; Lohmann MA; Garcia J; Castellvi S; Ramon y Cajal J; Gil-Moreno A; Xercavins J; Alameda F; Reventós J
J Steroid Biochem Mol Biol; 2008 Feb; 108(3-5):221-9. PubMed ID: 18061438
[TBL] [Abstract][Full Text] [Related]
11. Molecular pathology of endometrial carcinoma: practical aspects from the diagnostic and therapeutic viewpoints.
Llobet D; Pallares J; Yeramian A; Santacana M; Eritja N; Velasco A; Dolcet X; Matias-Guiu X
J Clin Pathol; 2009 Sep; 62(9):777-85. PubMed ID: 18977806
[TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of endometrial hyperplasia in HNPCC-suspicious patients may predict progression to endometrial carcinoma.
Sutter C; Dallenbach-Hellweg G; Schmidt D; Baehring J; Bielau S; von Knebel Doeberitz M; Gebert J
Int J Gynecol Pathol; 2004 Jan; 23(1):18-25. PubMed ID: 14668545
[TBL] [Abstract][Full Text] [Related]
13. [Endometrial carcinoma and precursor lesions].
Djordjević B; Stanojević Z
Srp Arh Celok Lek; 2007; 135(3-4):230-4. PubMed ID: 17642468
[TBL] [Abstract][Full Text] [Related]
14. Molecular bases of endometrial cancer: new roles for new actors in the diagnosis and the therapy of the disease.
Llauradó M; Ruiz A; Majem B; Ertekin T; Colás E; Pedrola N; Devis L; Rigau M; Sequeiros T; Montes M; Garcia M; Cabrera S; Gil-Moreno A; Xercavins J; Castellví J; Garcia A; Ramón y Cajal S; Moreno G; Alameda F; Vázquez-Levin M; Palacios J; Prat J; Doll A; Matías-Guiu X; Abal M; Reventós J
Mol Cell Endocrinol; 2012 Jul; 358(2):244-55. PubMed ID: 22037169
[TBL] [Abstract][Full Text] [Related]
15. Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway.
Mirabelli-Primdahl L; Gryfe R; Kim H; Millar A; Luceri C; Dale D; Holowaty E; Bapat B; Gallinger S; Redston M
Cancer Res; 1999 Jul; 59(14):3346-51. PubMed ID: 10416591
[TBL] [Abstract][Full Text] [Related]
16. [Genetic alterations and transformations in development and establishment of uterine endometrial carcinomas].
Inoue M
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Aug; 45(8):751-62. PubMed ID: 8371006
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide mutation analysis in precancerous lesions of endometrial carcinoma.
Li L; Yue P; Song Q; Yen TT; Asaka S; Wang TL; Beavis AL; Fader AN; Jiao Y; Yuan G; Shih IM; Song Y
J Pathol; 2021 Jan; 253(1):119-128. PubMed ID: 33016334
[TBL] [Abstract][Full Text] [Related]
18. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?
Alvarez T; Miller E; Duska L; Oliva E
Am J Surg Pathol; 2012 May; 36(5):753-61. PubMed ID: 22498825
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of the candidate tumor suppressor par-4 in endometrial cancer.
Moreno-Bueno G; Fernandez-Marcos PJ; Collado M; Tendero MJ; Rodriguez-Pinilla SM; Garcia-Cao I; Hardisson D; Diaz-Meco MT; Moscat J; Serrano M; Palacios J
Cancer Res; 2007 Mar; 67(5):1927-34. PubMed ID: 17332319
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis in endometrial cancer.
Caduff RF; Svoboda-Neumann SM; Johnston CM; Bartos RE; Frank TS
Verh Dtsch Ges Pathol; 1997; 81():219-27. PubMed ID: 9474873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
